Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check2 days agoChange DetectedAdded Melanoma as a disease focus and included MedlinePlus Genetics under related topics. The update situates the study within the melanoma context and provides convenient access to genetics-related resources for users.SummaryDifference0.2%

- Check9 days agoChange DetectedThe related topics section was edited to drop the Melanoma topic and the MedlinePlus Genetics link. This reduces navigational cross-links to disease context and genetics resources on the page.SummaryDifference0.2%

- Check16 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, indicating a new revision of the page. This reflects behind-the-scenes updates to the study record or its accompanying documents.SummaryDifference0.1%

- Check23 days agoChange DetectedA new site revision, v3.6.2, replaces the previous v3.6.0, representing a minor update to the page's template/backend rather than content changes. This update does not affect the displayed study information, eligibility criteria, or enrollment details.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now indicates that recruitment is closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a minor heading formatting change for Intervention/Treatment and an updated revision label.SummaryDifference0.6%

- Check45 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, signaling a small page update. No substantive changes to study details or content are evident from the changes shown.SummaryDifference0.1%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.